Bajaj HealthCare Limited (BAJAJHCARE.BO)
INR 579.15
(2.89%)
INR 579.15
(2.89%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 650.34 Million INR | -31.12% |
| 2022 | 944.16 Million INR | 42.39% |
| 2021 | 663.1 Million INR | -16.81% |
| 2020 | 797.13 Million INR | 238.08% |
| 2019 | 235.78 Million INR | 35.56% |
| 2018 | 173.92 Million INR | -19.01% |
| 2017 | 214.75 Million INR | -20.0% |
| 2016 | 268.45 Million INR | -14.63% |
| 2015 | 314.47 Million INR | 41.54% |
| 2014 | 222.17 Million INR | 52.76% |
| 2013 | 145.44 Million INR | -14.84% |
| 2012 | 170.79 Million INR | -1.99% |
| 2011 | 174.26 Million INR | 45.05% |
| 2010 | 120.14 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 650.34 Million INR | -31.12% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 650.34 Million INR | 0.0% |
| 2023 Q2 | 581.53 Million INR | 0.0% |
| 2022 Q2 | 654.01 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 944.16 Million INR | 42.39% |
| 2022 Q4 | 944.16 Million INR | 0.0% |
| 2021 Q2 | 762.87 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 663.1 Million INR | -16.81% |
| 2021 Q4 | 663.1 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 797.13 Million INR | 238.08% |
| 2020 Q4 | 797.13 Million INR | 0.0% |
| 2020 Q2 | 378.45 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q2 | 201.47 Million INR | 0.0% |
| 2019 FY | 235.78 Million INR | 35.56% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 235.78 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | 175.03 Million INR | -18.5% |
| 2018 Q4 | 173.92 Million INR | 0.0% |
| 2018 FY | 173.92 Million INR | -19.01% |
| 2018 Q3 | 173.92 Million INR | -0.63% |
| 2018 Q2 | 175.03 Million INR | 0.0% |
| 2017 Q4 | 214.75 Million INR | 0.0% |
| 2017 FY | 214.75 Million INR | -20.0% |
| 2017 Q3 | 214.75 Million INR | -11.48% |
| 2017 Q2 | 242.6 Million INR | 0.0% |
| 2017 Q1 | 242.6 Million INR | -9.63% |
| 2016 Q2 | 265.56 Million INR | 0.0% |
| 2016 FY | 268.45 Million INR | -14.63% |
| 2016 Q4 | 268.45 Million INR | 0.0% |
| 2016 Q3 | 268.45 Million INR | 1.09% |
| 2016 Q1 | 265.56 Million INR | -15.55% |
| 2015 Q3 | 299.19 Million INR | 32.7% |
| 2015 Q1 | 225.46 Million INR | 0.0% |
| 2015 Q2 | 225.46 Million INR | 0.0% |
| 2015 FY | 314.47 Million INR | 41.54% |
| 2015 Q4 | 314.47 Million INR | 5.11% |
| 2014 FY | 222.17 Million INR | 52.76% |
| 2013 FY | 145.44 Million INR | -14.84% |
| 2012 FY | 170.79 Million INR | -1.99% |
| 2011 FY | 174.26 Million INR | 45.05% |
| 2010 FY | 120.14 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -4789.812% |
| NATCO Pharma Limited | 53 Million INR | -1127.066% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -206.252% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 53450.697% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -176.507% |
| Alkem Laboratories Limited | 400 Million INR | -62.586% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -3.426% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -2236.345% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 96.954% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -82.721% |
| Brooks Laboratories Limited | 3.56 Million INR | -18142.496% |
| Divi's Laboratories Limited | 20 Million INR | -3151.725% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 89.143% |
| Eris Lifesciences Limited | 6.54 Billion INR | 90.064% |
| FDC Limited | 2.46 Million INR | -26272.466% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 57.127% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -340.583% |
| Granules India Limited | 689.71 Million INR | 5.707% |
| Gufic Biosciences Limited | 1.53 Billion INR | 57.76% |
| Hester Biosciences Limited | 1.81 Billion INR | 64.222% |
| Indoco Remedies Limited | 3.51 Billion INR | 81.51% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -482.611% |
| Ipca Laboratories Limited | 5.8 Billion INR | 88.795% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -760.586% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 64.559% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | 92.441% |
| Lupin Limited | 1.55 Billion INR | 58.118% |
| Mankind Pharma Limited | 248.67 Million INR | -161.522% |
| Medicamen Biotech Limited | 12.55 Million INR | -5079.968% |
| Medico Remedies Limited | 8.67 Million INR | -7399.366% |
| Megasoft Limited | 1.35 Billion INR | 52.077% |
| Piramal Pharma Limited | 24.83 Billion INR | 97.382% |
| RPG Life Sciences Limited | -30.3 Million INR | 2246.353% |
| Sigachi Industries Limited | 265.79 Million INR | -144.676% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -510.08% |
| Unichem Laboratories Limited | 382.22 Million INR | -70.149% |
| Wanbury Limited | 820 Million INR | 20.69% |
| Windlas Biotech Limited | 20.18 Million INR | -3122.721% |
| ZIM Laboratories Limited | 356 Million INR | -82.678% |
| Zydus Lifesciences Limited | 251 Million INR | -159.102% |
| Procter & Gamble Health Limited | 68.8 Million INR | -845.269% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -4555.964% |
| Bal Pharma Limited | 363.82 Million INR | -78.753% |
| Strides Pharma Science Limited | 6.71 Billion INR | 90.315% |
| Venus Remedies Limited | 386.8 Million INR | -68.135% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -162486.25% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 53.649% |
| Shilpa Medicare Limited | 5.6 Billion INR | 88.39% |
| Aarti Drugs Limited | 2.75 Billion INR | 76.379% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 93.558% |
| Valiant Laboratories Limited | 746.63 Million INR | 12.896% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -175.104% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 38.548% |
| Themis Medicare Limited | 267.74 Million INR | -142.902% |
| Hikal Limited | 4.22 Billion INR | 84.62% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 95.945% |
| Sequent Scientific Limited | 1.42 Billion INR | 54.432% |
| Novartis India Limited | 50.7 Million INR | -1182.732% |
| Wockhardt Limited | 8.91 Billion INR | 92.701% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 97.947% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -44.777% |
| Morepen Laboratories Limited | 33.64 Million INR | -1833.249% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -387.0% |